USANA Health Sciences Inc
Open
19.66 -1.16
Overview
Share price change
24h
Min
19.26
Max
20.19
Income | 5.1M -1.6M |
|---|---|
Sales | 13M 226M |
P/E Sector Avg | 32 27.509 |
Profit margin | -0.705 |
Employees | 1,570 |
EBITDA | 16M 28M |
Next Earnings | 21 lip 2026 |
|---|
Market Cap | -40M 343M |
|---|---|
Previous open | 20.82 |
Previous close | 19.66 |
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
USANA Health Sciences Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
USANA Health Sciences Inc Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
